| 85 |
disrupted |
protein domain specific binding
(GO:0019904)
|
|
158: N/A, Interferences with SH-/selen-proteins
|
| 84 |
occurrence |
protein binding
(GO:0005515)
|
Selenium-Binding Proteins
(MESH:D051137)
|
261: Binding, SH-/selen-proteins
|
| 83 |
decreased |
population growth rate
(PCO:0000008)
|
|
4 Events
|
| 82 |
increased |
paralysis
(MP:0000753)
|
|
5 Events
|
| 81 |
increased |
hyperactivity
(MP:0001399)
|
|
3 Events
|
| 80 |
increased |
ataxia
(MP:0001393)
|
|
3 Events
|
| 79 |
increased |
respiratory distress
(MP:0001954)
|
|
445: Respiratory distress/arrest
|
| 78 |
increased |
|
decreased heart rate
(MESH:D001919)
|
444: Increased, Atrioventricular block and bradycardia
|
| 77 |
increased |
|
atrioventricular block
(MESH:D054537)
|
444: Increased, Atrioventricular block and bradycardia
|
| 76 |
increased |
|
acetylcholine
(CHEBI:15355)
|
10: Acetylcholine accumulation in synapses
|
| 75 |
decreased |
acetylcholinesterase activity
(GO:0003990)
|
acetylcholinesterase
(PR:000003626)
|
12: Acetylcholinesterase (AchE) Inhibition
|
| 74 |
functional change |
DNA repair
(GO:0006281)
|
deoxyribonucleic acid
(CHEBI:16991)
|
None
|
| 73 |
increased |
mutation
(MESH:D009154)
|
deoxyribonucleic acid
(CHEBI:16991)
|
3 Events
|
| 72 |
increased |
DNA alkylation
(GO:0006305)
|
deoxyribonucleic acid
(CHEBI:16991)
|
97: Alkylation, DNA
|
| 71 |
increased |
Disease Susceptibility
(MESH:D004198)
|
|
323: Increased, Disease susceptibility
|
| 70 |
increased |
suppression of host defenses
(GO:0044414)
|
immune system
(UBERON:0002405)
|
403: Suppression, Immune system
|
| 69 |
increased |
I-kappaB phosphorylation
(GO:0007252)
|
NF-kappa-B inhibitor
(PR:000003292)
|
145: Induction, IKB inhibitory protein
|
| 68 |
decreased |
|
lymphocyte
(CL:0000542)
|
168: Decreased, Lymphocytes
|
| 67 |
decreased |
cytokine production involved in inflammatory response
(GO:0002534)
|
|
152: Suppression, Inflammatory cytokines
|
| 66 |
decreased |
I-kappaB kinase/NF-kappaB signaling
(GO:0007249)
|
transcription factor NF-kappa-B subunit
(PR:000001753)
|
202: Inhibition, Nuclear factor kappa B (NF-kB)
|
| 65 |
increased |
glucocorticoid receptor activity
(GO:0004883)
|
glucocorticoid receptor
(PR:000011406)
|
3 Events
|
| 64 |
decreased |
memory
(GO:0007613)
|
|
341: Impairment, Learning and memory
|
| 63 |
decreased |
synaptic signaling
(GO:0099536)
|
|
2 Events
|
| 62 |
decreased |
synapse assembly
(GO:0007416)
|
synapse
(GO:0045202)
|
385: Decrease of synaptogenesis
|
| 61 |
decreased |
glutamate secretion, neurotransmission
(GO:0061535)
|
glutamate(1-)
(CHEBI:14321)
|
None
|